Furthermore, SHROOM4 appears to regulate the tumor microenvironment (TME) through mechanisms such as angiogenesis and cell cycle modulation mediated by ANGPTL7 and PTPN13 in LUAD, thereby influencing cancer progression. This evidence concerns the gene ANGPTL7 and neoplasm.